Edwards Lifesciences Corp — Director's Dealing 2018

May 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2018-05-08

Reporting Person: Lemercier Jean-Luc M (CVP, EMEA, Canada, Latin Amer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-08	Common Stock	F	56.0000	$136.0900	Disposed	38784.0233	Direct
2018-05-09	Common Stock	M	5634.0000	$44.6150	Acquired	44418.0233	Direct
2018-05-09	Common Stock	S	5634.0000	$134.9100	Disposed	38784.0233	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-09	Employee Stock Option (Right to Acquire)	$44.6150	M	5634.0000	Disposed	2018-05-11	Common Stock (5634.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2018.